Henley J M, Ambrosini A, Rodriguez-Ithurralde D, Sudan H, Brackley P, Kerry C, Mellor I, Abutidze K, Usherwood P N, Barnard E A
Medical Research Council Molecular Neurobiology Unit, Medical Research Council Centre, Cambridge, United Kingdom.
Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4806-10. doi: 10.1073/pnas.89.11.4806.
We have purified and characterized two vertebrate excitatory amino acid ionotropic receptors from the Xenopus central nervous system. Each is a unitary receptor (i.e., having more than one class of excitatory amino acid agonist specificity within one protein oligomer). The first is a unitary non-N-methyl-D-aspartate (non-NMDA) receptor and the second is a unitary NMDA/non-NMDA receptor. The specific agonist-activated channel activity and pharmacology of each type were recognized by patch-clamping lipid bilayers in which the isolated protein was reconstituted. In the second case, the NMDA and the non-NMDA sites could not be physically separated and exhibited functional interaction. Parallel evidence for this was obtained when poly(A) RNA from Xenopus brain was translated in oocytes: a noncompetitive inhibition of the response to L-kainate is produced by NMDA to a maximum depression of 30% at 1 mM NMDA. Each isolated oligomer contains 42-kDa subunits of the non-NMDA ligand binding type, but the second type has an additional NMDA-receptor-specific 100-kDa subunit. Thus, a subunit-exchange hypothesis can account for the known multiplicity of excitatory amino acid receptor types.
我们从非洲爪蟾的中枢神经系统中纯化并鉴定了两种脊椎动物兴奋性氨基酸离子型受体。每一种都是单一受体(即,在一个蛋白质寡聚体内具有不止一类兴奋性氨基酸激动剂特异性)。第一种是单一的非N-甲基-D-天冬氨酸(非NMDA)受体,第二种是单一的NMDA/非NMDA受体。每种类型的特异性激动剂激活通道活性和药理学特性通过膜片钳脂质双层来识别,在该双层中重组了分离出的蛋白质。在第二种情况下,NMDA和非NMDA位点无法在物理上分离,并表现出功能相互作用。当从非洲爪蟾脑中提取的多聚腺苷酸RNA在卵母细胞中翻译时,也获得了平行的证据:NMDA对L-谷氨酸钾反应产生非竞争性抑制,在1 mM NMDA时最大抑制率为30%。每个分离出的寡聚体都包含非NMDA配体结合型的42 kDa亚基,但第二种类型还有一个额外的NMDA受体特异性100 kDa亚基。因此,亚基交换假说可以解释已知的兴奋性氨基酸受体类型的多样性。